Riskpilot← Back to searchSign inGet full accessBlomstrand Naprapati AB
ABActiveOrg 5590368535Byggmästarvägen 17Physiotherapy activities · NACE 8695Est. 20151 employees
Revenue 2025
SEK 907K
+18% vs 2024
EBITDA margin
5.7%
+224% vs 2024
Equity ratio
84.0%
Financial strength
Net profit 2025
SEK 48K
+219% vs 2024
| Revenue | SEK 907K | +18% |
| EBITDA | SEK 51K | +224% |
| Net profit | SEK 48K | +219% |
| Total assets | SEK 182K | +13% |
| Equity | SEK 153K | +46% |
| Employees | 1 | — |
Legal name
Blomstrand Naprapati AB
Org number
5590368535
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
24 november 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Blomstrand, Rebecka Inger Cecilia
Company purpose
Bolaget ska bedriva verksamhet inom naprapati, medicinsk akupunktur och ergonomi samt därmed förenlig verksamhet.
Address
Byggmästarvägen 17
Email
rebecka@rebeckablomstrand.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 866 | 720 | 801 | 769 | 907 |
| Staff expenses | — | −467 | −421 | −514 | −557 |
| EBITDA | −7 | −102 | 85 | −41 | 51 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −7 | −102 | 85 | −41 | 51 |
| Net financials | — | −0 | 0 | 0 | 0 |
| Profit before tax | −8 | −102 | 85 | −41 | 52 |
| Tax | −0 | — | — | — | −3 |
| Net profit | −8 | −102 | 85 | −41 | 48 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 185 | 127 | 206 | 161 | 182 |
| Equity | 132 | 60 | 145 | 104 | 153 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 53 | 67 | 61 | 56 | 29 |
| Total debt | 53 | 67 | 61 | 56 | 29 |
EBITDA margin
5.7%
This company
15.8%
Market median
-64% vs market
20212025
Equity ratio
84.0%
This company
38.2%
Market median
+120% vs market
20212025
Return on equity
31.7%
This company
18.4%
Market median
+72% vs market
20212025
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20212025
Asset turnover
4.99×
This company
1.12×
Market median
+346% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Blomstrand Naprapati AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rebecka Inger Cecilia Blomstrand | Chairman | 0 companies |
| Seppo Matias Maajola | Deputy Board Member | 0 companies |
| Annika Margareta Hertzsch | Board of Directors | 0 companies |
| Annika Maria Kristina Blomstrand | Deputy Board Member | 0 companies |
| Johan Marcus Wallberg | Board of Directors | 0 companies |